These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 36283077)

  • 1. Chemical Probes to Control and Visualize Lipid Metabolism in the Brain.
    Punt JM; van der Vliet D; van der Stelt M
    Acc Chem Res; 2022 Nov; 55(22):3205-3217. PubMed ID: 36283077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical Proteomics Maps Brain Region Specific Activity of Endocannabinoid Hydrolases.
    Baggelaar MP; van Esbroeck AC; van Rooden EJ; Florea BI; Overkleeft HS; Marsicano G; Chaouloff F; van der Stelt M
    ACS Chem Biol; 2017 Mar; 12(3):852-861. PubMed ID: 28106377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Endocannabinoid-Metabolizing Enzymes in Peripheral Tissues Following Developmental Chlorpyrifos Exposure in Rats.
    Buntyn RW; Alugubelly N; Hybart RL; Mohammed AN; Nail CA; Parker GC; Ross MK; Carr RL
    Int J Toxicol; 2017; 36(5):395-402. PubMed ID: 28820005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release.
    Lee SH; Ledri M; Tóth B; Marchionni I; Henstridge CM; Dudok B; Kenesei K; Barna L; Szabó SI; Renkecz T; Oberoi M; Watanabe M; Limoli CL; Horvai G; Soltesz I; Katona I
    J Neurosci; 2015 Jul; 35(27):10039-57. PubMed ID: 26157003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocannabinoid-Based Therapies.
    Piomelli D; Mabou Tagne A
    Annu Rev Pharmacol Toxicol; 2022 Jan; 62():483-507. PubMed ID: 34516291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors.
    Bedse G; Bluett RJ; Patrick TA; Romness NK; Gaulden AD; Kingsley PJ; Plath N; Marnett LJ; Patel S
    Transl Psychiatry; 2018 Apr; 8(1):92. PubMed ID: 29695817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of mice lacking candidate N-acyl ethanolamine biosynthetic enzymes provides evidence for multiple pathways that contribute to endocannabinoid production in vivo.
    Simon GM; Cravatt BF
    Mol Biosyst; 2010 Aug; 6(8):1411-8. PubMed ID: 20393650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid and profound rewiring of brain lipid signaling networks by acute diacylglycerol lipase inhibition.
    Ogasawara D; Deng H; Viader A; Baggelaar MP; Breman A; den Dulk H; van den Nieuwendijk AM; Soethoudt M; van der Wel T; Zhou J; Overkleeft HS; Sanchez-Alavez M; Mori S; Nguyen W; Conti B; Liu X; Chen Y; Liu QS; Cravatt BF; van der Stelt M
    Proc Natl Acad Sci U S A; 2016 Jan; 113(1):26-33. PubMed ID: 26668358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) expression in mouse brain: A new perspective on N-acylethanolamines as neural signaling molecules.
    Egertová M; Simon GM; Cravatt BF; Elphick MR
    J Comp Neurol; 2008 Feb; 506(4):604-15. PubMed ID: 18067139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-hydroxyacetamide carbamates as a highly potent and selective class of endocannabinoid hydrolase inhibitors.
    Niphakis MJ; Johnson DS; Ballard TE; Stiff C; Cravatt BF
    ACS Chem Neurosci; 2012 May; 3(5):418-26. PubMed ID: 22860211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB₁R signaling and anxiety-like behavior.
    Imperatore R; Morello G; Luongo L; Taschler U; Romano R; De Gregorio D; Belardo C; Maione S; Di Marzo V; Cristino L
    J Neurochem; 2015 Nov; 135(4):799-813. PubMed ID: 26223500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the effects of reuptake and hydrolysis inhibition on interstitial endocannabinoid levels in the brain: an in vivo microdialysis study.
    Wiskerke J; Irimia C; Cravatt BF; De Vries TJ; Schoffelmeer AN; Pattij T; Parsons LH
    ACS Chem Neurosci; 2012 May; 3(5):407-17. PubMed ID: 22860210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
    Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
    Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct Activity of Endocannabinoid-Hydrolyzing Enzymes MAGL and FAAH in Key Regions of Peripheral and Central Nervous System Implicated in Migraine.
    Della Pietra A; Giniatullin R; Savinainen JR
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of receptors and enzymes for endocannabinoids in NSC-34 cells: relevance for in vitro studies with cannabinoids in motor neuron diseases.
    Moreno-Martet M; Mestre L; Loría F; Guaza C; Fernández-Ruiz J; de Lago E
    Neurosci Lett; 2012 Feb; 508(2):67-72. PubMed ID: 22206832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo.
    Long JZ; Nomura DK; Vann RE; Walentiny DM; Booker L; Jin X; Burston JJ; Sim-Selley LJ; Lichtman AH; Wiley JL; Cravatt BF
    Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20270-5. PubMed ID: 19918051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocannabinoid metabolism and transport as targets to regulate intraocular pressure.
    Miller S; Daily L; Dharla V; Gertsch J; Malamas MS; Ojima I; Kaczocha M; Ogasawara D; Straiker A
    Exp Eye Res; 2020 Dec; 201():108266. PubMed ID: 32979397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of endocannabinoid neuronal uptake and hydrolysis as strategies for developing anxiolytic drugs.
    Batista LA; Gobira PH; Viana TG; Aguiar DC; Moreira FA
    Behav Pharmacol; 2014 Sep; 25(5-6):425-33. PubMed ID: 25083569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure to tobacco smoke during the early postnatal period modifies receptors and enzymes of the endocannabinoid system in the brainstem and striatum in mice.
    Torres LH; Balestrin NT; Spelta LEW; Duro SO; Pistis M; Marcourakis T
    Toxicol Lett; 2019 Mar; 302():35-41. PubMed ID: 30553937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipidomics profile of a NAPE-PLD KO mouse provides evidence of a broader role of this enzyme in lipid metabolism in the brain.
    Leishman E; Mackie K; Luquet S; Bradshaw HB
    Biochim Biophys Acta; 2016 Jun; 1861(6):491-500. PubMed ID: 26956082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.